Rheonix, Inc. (Rheonix) is a diagnostic systems developer. It develops patented Rheonix CARD system and EncompassMDx instrument. Rheonix CARD system manipulates reagents with an internal active fluidized network of pumps, valves and channels. The company performs molecular techniques such as sample preparation, amplification and detection. EncompassMDx instrument combines its unique technology and industry standard automation components in order to bring new diagnostic tests to the market. Its elements include liquid handler with disposable pipette tips, bulk reagent packages, drive components, hybridization heaters, barcode reader and imager. Rheonix is headquartered in Ithaca, New York, the US.

This report is a source for data, analysis and actionable intelligence on the Rheonix, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.

Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.

Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.

Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.

Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.